These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5035130)

  • 1. Surveillance of drug adverse reactions.
    Campbell JS; Henderson IW
    Can Med Assoc J; 1972 Jun; 106(12):1285. PubMed ID: 5035130
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Registration of adverse effects in drug therapy].
    Skobba TJ
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):6-9. PubMed ID: 5426192
    [No Abstract]   [Full Text] [Related]  

  • 4. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Available list of adverse effects].
    Liljestrand A
    Lakartidningen; 1976 Apr; 73(15):1397. PubMed ID: 1263655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Responsibility for drug reactions].
    Naess K
    Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of adverse drug reaction in a hospital environment].
    Honorato J; Giráldez J; Mart'i Mass'o R; Fos D; Velasco JL; S'anchez H
    Rev Med Univ Navarra; 1976; 20():209-11. PubMed ID: 1019512
    [No Abstract]   [Full Text] [Related]  

  • 8. [Local reporting of adverse effects--an experimental work at the main hospital].
    Hallberg L; Lundborg P
    Lakartidningen; 1974 May; 71(19):1916-7. PubMed ID: 4133506
    [No Abstract]   [Full Text] [Related]  

  • 9. The Swedish Adverse Drug Reaction Committee: an important tool for safer drug therapy.
    Böttiger LE
    QRB Qual Rev Bull; 1981 Feb; 7(2):14-20. PubMed ID: 6785702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Work of the committee on drug side effects].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse drug effects: evaluation of four secondary reference sources.
    Lyon RA
    Hosp Formul; 1985 Mar; 20(3):315-7, 320-1. PubMed ID: 10270307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of drugs. Compiled and evaluated by the Committee on Drugs].
    Ochsenfahrt H
    Fortschr Med; 1984 Apr; 102(13):355-60. PubMed ID: 6724463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of drug adverse reactions.
    Can Med Assoc J; 1972 Mar; 106(5):535-6. PubMed ID: 5021155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reports on drug side effects for the period 1973-1974].
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1243-7. PubMed ID: 1162667
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society].
    Homann G
    Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792
    [No Abstract]   [Full Text] [Related]  

  • 20. The Drug Spotlight Program.
    Aagaard GN
    J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.